About the Company
adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. our unique, yea...
Read complete descriptionCompany Details
Website & Contact
- Website:adimab.com
- Phone:(603) 643-7110
- Email Addresses Found: 145 verified contacts View all email addresses
Business Details
- Industry:biotechnology
- Company Size: 51-200 employees
- Founded: 2007
Location & Address
- Street Address: 7 lucent drive
- City: Lebanon
- State/Region: New Hampshire
- Postal Code: 03766
- Country:United States
Email Database Statistics
- Total Email Addresses: 145 contacts Complete database of professional emails
- Personal Email Addresses: 141 individual contacts Direct employee email addresses
- Department Email Addresses: 4 role-based contacts General department and role-based emails
Domain Registration Details
- Domain Registrant: Name.com, Inc.
- Registration Date: March 13th 2007, 10:53:08 pm
- Domain Registrar: http://www.name.com
Discover All Email Addresses for the Domain
Use our domain search tool to find professional email addresses from adimab.com. Furthermore, our comprehensive database helps you connect with the right people at Adimab.com.
Try it free - Find up to 10 email addresses at no cost!
Give it a quick try with zapier.com.
Email Data Sources
All email addresses are sourced from publicly available information using our TombaWebPublic crawler. Additionally, we maintain transparency by showing exactly where each email was discovered.
Total verified sources: 85
Source URL | Date Discovered |
---|---|
https://tomba.io/robot | |
https://paganresearch.io/contact/88020 | |
https://pdfslide.net/documents/how-to-make-the-... | |
https://fdocuments.net/document/how-to-make-the... | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://www.adimab.com/leadership-team | |
https://tomba.io/robot | |
https://pdfslide.net/documents/purification-of-... | |
https://fdocuments.net/document/purification-of... | |
https://tomba.io/robot | |
https://pdfslide.net/documents/biophysical-prop... | |
https://documents.pub/document/biophysical-prop... | |
https://fdocuments.net/document/biophysical-pro... | |
https://www.research.gov/common/attachment/Comm... | |
https://tomba.io/robot | |
https://growjo.com/company/Adimab | |
https://eventible.com/speakers/profile/tushar-j... | |
https://tomba.io/robot | |
https://sciforschenonline.org/journals/blood-di... | |
https://www.adimab.com/leadership-team | |
http://app.cxoreach.com/contacts/?page_no=14406 | |
https://cxoreach.com/companies/details.php?doma... | |
https://growjo.com/company/Adimab | |
https://pdfslide.net/documents/biophysical-prop... | |
https://tomba.io/robot | |
https://www.adimab.com/leadership-team | |
https://growjo.com/company/Adimab | |
https://pdfslide.net/documents/biophysical-prop... | |
https://pdfslide.net/documents/biophysical-prop... | |
https://documents.pub/document/biophysical-prop... | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://app.lead411.com/people/p-2-14-14.html | |
https://growjo.com/company/Adimab | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://growjo.com/company/Adimab | |
https://pdfslide.net/documents/broad-sarbecovir... | |
https://pdfslide.net/documents/infectious-disea... | |
https://pdfslide.net/documents/infectious-disea... | |
https://fdocuments.net/document/coronavirus-bro... | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://cxoreach.com/contacts/details.php?id=16... | |
https://slideheaven.com/directory-of-members368... | |
http://app.cxoreach.com/contacts/?page_no=12159 | |
https://cxoreach.com/companies/details.php?doma... | |
https://pdfslide.net/documents/biophysical-prop... | |
https://pdfslide.net/documents/biophysical-prop... | |
https://documents.pub/document/biophysical-prop... | |
https://fdocuments.net/document/biophysical-pro... | |
https://www.adimab.com/leadership-team | |
https://paganresearch.io/contact/88020 | |
https://www.adimab.com/leadership-team | |
https://growjo.com/company/Adimab | |
https://www.adimab.com/leadership-team | |
https://www.adimab.com/news/2020-07-16-adagio | |
https://www.adimab.com/news/2020-01-10-adimab-2... | |
https://paganresearch.io/contact/43170 | |
https://www.biospace.com/press-releases/adimab-... | |
http://app.cxoreach.com/contacts/?page_no=11449 | |
https://cxoreach.com/companies/details.php?doma... | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://tomba.io/robot | |
https://www.adimab.com/leadership-team | |
https://growjo.com/company/Adimab | |
https://usa-business-finder.com/categories/groc... | |
https://amagmatx.com/about/ | |
https://www.adimab.com/news/2009-10-01-series-d | |
https://www.adimab.com/news/2008-10-24-guy-van-... | |
https://www.adimab.com/news/2008-11-20-series-c | |
https://www.atum.bio/adimab-and-dna2-0-enter-ex... |
Showing 85 sources. all sources are regularly updated to ensure data accuracy.